Skip to content
DefDex

Federal award

MYLAN PHARMACEUTICALS INC

SPE2D216D0042

Contract vehicle (IDV)IDV: ceiling is not spending

Obligated and Ceiling

Obligated (net)
$0.00
Vehicle ceiling (not spending)
$121,498,092.60
Current value
—
Gross positive obligations
$0.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
MYLAN PHARMACEUTICALS INC · NDN1MYB8DKK5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
WALLACE PHARMACEUTICALS INC. · EJPJLYD1GFZ5
Awarding agency
Department of Defense · sub-agency 97AS · office SPE2D2
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
SPE2D216D0042
Award type code
B
Actions
1 · Sep 13, 2016 to Sep 13, 2016
Why it is listed
contract vehicle (IDV)

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 13, 2016FY20160—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.